Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.7462
-0.0591 (-7.34%)
At close: Sep 17, 2026, 4:00 PM EDT
0.7653
+0.0191 (2.56%)
Pre-market: Sep 18, 2026, 8:09 AM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $219.95 million as of September 17, 2026. Its market cap has decreased by -10.46% in one year.
Market Cap
219.95M
Enterprise Value
68.26M
1-Year Change
-10.46%
Ranking
Category
Stock Price
$0.75
ChartMarket Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $219.95M, a decrease of -90.29%. That is a compound annual growth rate of -36.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 219.95M | -67.87% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Compugen | 233.02M |
| Whitehawk Therapeutics | 232.60M |
| YD Bio | 227.84M |
| Adagene | 226.27M |
| Keros Therapeutics | 225.24M |
| Anavex Life Sciences | 223.40M |
| Protara Therapeutics | 218.65M |
| Protalix BioTherapeutics | 217.54M |